Study Stopped
The FB4 trial has been terminated due to COVID-19.
FB4 (Framingham, Boston, Bloomington, Birmingham, and Baylor)
Macronutrients and Body Fat Accumulation: A Mechanistic Feeding Study
1 other identifier
interventional
166
1 country
1
Brief Summary
This study will evaluate the effects of dietary carbohydrate and sugar consumption, independent of energy content, on body fatness and metabolism in a rigorous feeding study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2017
CompletedFirst Posted
Study publicly available on registry
January 9, 2018
CompletedStudy Start
First participant enrolled
May 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 3, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 3, 2020
CompletedJune 18, 2021
October 1, 2020
2 years
December 29, 2017
June 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body fat mass
Body composition assessed using a multi-component model
Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)
Secondary Outcomes (33)
Lean body mass
Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)
Body weight
Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)
Total energy expenditure (TEE)
Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)
Resting energy expenditure (REE)
Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)
Physical activity level, (moderate to vigorous)
Measurements made daily during 2 weeks at PWL, 2 weeks at END, and alternating non-assessment weeks of the residential phase and integrated into a unified outcome
- +28 more secondary outcomes
Other Outcomes (34)
1,5-anhydroglucitol (1,5-AG)
Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)
Lipoprotein particle subfraction distribution
Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)
Fibrinogen
Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)
- +31 more other outcomes
Study Arms (3)
Very-Low Carbohydrate Diet
EXPERIMENTALFeeding study. Dietary composition (approximately): 75% fat
High-Carbohydrate Low-Sugar Diet
EXPERIMENTALFeeding study. Dietary composition (approximately): 25% fat 0% added sugars.
High-Carbohydrate High-Sugar Diet
EXPERIMENTALFeeding study. Dietary composition (approximately): 25% fat, 20% added sugars.
Interventions
Food provision throughout the study: 1) Run-In Phase (VLC diet, weight loss); 2) Residential Phase (3 different test diets, weight-loss maintenance).
Eligibility Criteria
You may qualify if:
- Aged 18 to 50 years
- BMI ≥ 27 kg/m2
- Weight ≤ 350 lb
- Medical clearance from a primary care provider
- Willingness to follow a VLC weight-loss diet
- Willingness to reside in a research unit for 3 months and eat/drink only provided study foods and beverages
- No major food allergies or aversions
- Willingness to obtain seasonal flu shot or provide documentation of flu shot for current flu season (winter/spring cohort only)
- Willingness to discuss work options (e.g., remote work) with employer, and make appropriate arrangements prior to the Residential phase.
You may not qualify if:
- Change in body weight ≥ 10% during prior 6 months
- Specialized diets (e.g., for medical or religious reasons)
- Chronic use of any medication or dietary supplement that could affect study outcomes (e.g., insulin, metformin, thyroxine)
- Current smoking (1 cigarette in the last week)
- Greater than moderate alcohol consumption (\> 14 drinks/wk) or history of binge drinking (≥5 drinks in 1 day within past 6 months)
- Physician diagnosis of a major medical illness or eating disorder
- History of kidney stones
- Laboratory tests: ALT\>2x upper limit; abnormal HgA1c; abnormal TSH; abnormal creatinine; abnormal uric acid (using the male upper limit for both sexes)
- Failed criminal offender background check or sex offender background check
- Use of recreational drugs
- Current diagnosis or history of kidney stones, gout, or gall stones; or removal of gall bladder
- Exercise restrictions or at high risk for complications during exercise
- Menopausal
- Any change in birth control medication during the 3 months prior to enrollment
- Pregnancy or lactation during the 12 months prior to enrollment, or intent to become pregnant during study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Children's Hospitallead
- Indiana Universitycollaborator
- University of Alabama at Birminghamcollaborator
- Framingham State Universitycollaborator
- Baylor Universitycollaborator
Study Sites (1)
Warren Conference Center and Inn
Ashland, Massachusetts, 01721, United States
Related Publications (5)
Ludwig DS, Friedman MI. Increasing adiposity: consequence or cause of overeating? JAMA. 2014 Jun 4;311(21):2167-8. doi: 10.1001/jama.2014.4133. No abstract available.
PMID: 24839118BACKGROUNDEbbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012 Jun 27;307(24):2627-34. doi: 10.1001/jama.2012.6607.
PMID: 22735432BACKGROUNDWong MC, Bennett JP, Leong LT, Tian IY, Liu YE, Kelly NN, McCarthy C, Wong JMW, Ebbeling CB, Ludwig DS, Irving BA, Scott MC, Stampley J, Davis B, Johannsen N, Matthews R, Vincellette C, Garber AK, Maskarinec G, Weiss E, Rood J, Varanoske AN, Pasiakos SM, Heymsfield SB, Shepherd JA. Monitoring body composition change for intervention studies with advancing 3D optical imaging technology in comparison to dual-energy X-ray absorptiometry. Am J Clin Nutr. 2023 Apr;117(4):802-813. doi: 10.1016/j.ajcnut.2023.02.006. Epub 2023 Feb 14.
PMID: 36796647DERIVEDJansen LT, Yang N, Wong JMW, Mehta T, Allison DB, Ludwig DS, Ebbeling CB. Prolonged Glycemic Adaptation Following Transition From a Low- to High-Carbohydrate Diet: A Randomized Controlled Feeding Trial. Diabetes Care. 2022 Mar 1;45(3):576-584. doi: 10.2337/dc21-1970.
PMID: 35108378DERIVEDWong JMW, Yu S, Ma C, Mehta T, Dickinson SL, Allison DB, Heymsfield SB, Ebbeling CB, Ludwig DS. Stimulated Insulin Secretion Predicts Changes in Body Composition Following Weight Loss in Adults with High BMI. J Nutr. 2022 Mar 3;152(3):655-662. doi: 10.1093/jn/nxab315.
PMID: 34587231DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David S Ludwig, MD, PhD
Boston Children's Hospital
- PRINCIPAL INVESTIGATOR
David B Allison, PhD
Indiana University, Bloomington
- STUDY DIRECTOR
Cara B Ebbeling, PhD
Boston Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Assessors conducting analyses of biospecimens, laboratory personnel, DXA technologists, and research nurses were blinded to random group assignment. They were not involved in the randomization process or any aspects of the intervention. The statistical team worked with masked labels for the diet arms.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-Director, New Balance Foundation Obesity Prevention Center
Study Record Dates
First Submitted
December 29, 2017
First Posted
January 9, 2018
Study Start
May 9, 2018
Primary Completion
May 3, 2020
Study Completion
May 3, 2020
Last Updated
June 18, 2021
Record last verified: 2020-10